Organisation paid for research Program year 2025 Source: CMS Open Payments

Amr Norman

Neither a doctor nor a teaching hospital

Research payments

$118,373

161 payments

Through program year 2025, Amr Norman is reported as receiving $118,373 in research payments, across 161 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$10,055	109
2024	Research	$70,652	8
2023	Research	$37,665	44

Breakdown

Who paid Research payments · program years 2023–2025

Vertex Pharmaceuticals Incorporated $47,364 2 payments
Novo Nordisk AS $33,000 46 payments
Boehringer Ingelheim International GmbH $31,848 110 payments
Boehringer Ingelheim Pharmaceuticals, Inc. $6,161 3 payments

Studies the money was for Research payments · program years 2023–2025

A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel-design Study of the Efficacy and Safety of VX-548 in Subjects With Painful Lumbosacral Radiculopathy $47,364 2 payments
Obesity Long term safety in patients with CV risk $27,954 4 payments
Nn9535-4321 $17,661 39 payments
Nn9924-4635 $15,339 7 payments
A Phase 3, randomised, double-blind, parallel-group, event-driven, cardiovascular safety study with BI 456906 administered subcutaneously compared with placebo in participants with overweight or obesity with established cardiovascular disease (CVD) or chronic kidney disease, and/or at least two weight-related complications or risk factors for CVD $10,055 109 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.